Delta Gold Technologies PLC
("Delta Gold" or the "Company")
Half Year Report for the period from incorporation to 31 October 2025
Delta Gold Technologies Plc is pleased to present its half year report for the period from incorporation to the 31 October 2025.
CHAIRMAN’S INTERIM STATEMENT
Introduction
It is my privilege to present this Chairman’s Statement for Delta Gold Technologies Plc (“Delta”) at a pivotal moment in the Company’s development. Since incorporation in early 2025, Delta has moved with purpose, securing a core intellectual property strategy, establishing a world-class research partnership, and executing a successful initial public offering, all within the same calendar year 2025.
Our aim is to identify, develop and commercialise high-value intellectual property (“IP”) in the high growth quantum computing sector, with an initial focus on the use of nano-scale gold and other advanced materials. Through a disciplined, research-led approach, we aim to build a portfolio of assets that exploits unique physical properties to address key technical challenges, particularly qubit stability and scalability. Key to our strategy is the opportunity to establish a dedicated London-listed platform providing small-cap equity investors with focused exposure to frontier technologies, an area where there are currently very few pure-play investment opportunities available in the public markets.
The Board believes the combination of strategic vision, research excellence and public market access, positions Delta to capitalise on long-term structural growth in advanced computing technologies.
Financial Results
For the period from incorporation to 31 October 2025, the Company recorded a loss of £126,431, reflecting its early-stage investment in building a credible research and intellectual property platform. The loss comprised £72,210 in administrative expenses and £54,221 in apportioned R&D charges associated with the University of Toronto research programme. As at the period end, the Company held cash reserves of £47,443.
Following the period end, the Company achieved a major strategic milestone with its successful admission to trading on the Access Segment of the AQSE Growth Market on 1 December 2025. Admission was accompanied by a £2.5 million equity fundraising through a Placing and Subscription of 25,000,000 new Ordinary Shares at 10 pence per share, establishing an initial market capitalisation of approximately £7.8 million.
This capital significantly strengthens Delta’s financial position at a formative stage in its development and provides the resources required to advance the multi-year University of Toronto research programme, secure and protect emerging intellectual property, and support ongoing working capital needs. The fundraising also broadens the Company’s shareholder base and enhances its ability to pursue additional sponsored research opportunities aligned with its strategy of building a high-value portfolio of quantum-focused IP assets.
Asset Overview and Progress
Delta’s principal asset is the sponsored Research Agreement with the University of Toronto, a globally respected institution in materials science and quantum technology. Under this agreement, Delta funds a multi-year research programme led by experts in nano-materials and quantum physics, with the opportunity to secure exclusive global licensing rights to intellectual property developed through the programme. This structure ensures that Delta’s shareholders directly benefit from research outputs that successfully transition from concept to commercial IP.
In less than twelve months since incorporation, the Company has achieved significant operational milestones, including negotiation and execution of the University of Toronto (“UofT”) research partnership, onboarding of research personnel, and commencement of sponsored research activities. This rapid progression reflects the Board’s commitment to building a credible platform for innovation and long-term value creation in the London market.
In parallel with our core research programme, the Company continues to explore complementary sponsored research opportunities to expand its intellectual property portfolio and diversify future potential revenue streams.
Successful IPO
On 1 December 2025, Delta successfully commenced trading on the Access Segment of the AQSE Growth Market (Aquis Stock Exchange) under the ticker symbol DGQ, raising gross proceeds of approximately £2.5 million through a Placing and Subscription of 25,000,000 new ordinary shares at an issue price of 10p per share.
The IPO completed with a strong initial shareholder base and brought the Company’s market capitalisation to approximately £7.8 million on admission, reflecting early investor confidence in Delta’s strategy and prospects.
We are grateful for the support of our corporate adviser, Orana Corporate LLP, and legal counsel, Haynes Boone, whose expertise was instrumental in achieving a successful public listing in a highly competitive market environment. We are also grateful for the support from our existing and new shareholders.
Admission to trading on a recognised public market represents a transformational milestone for Delta. It provides enhanced visibility with institutional and retail investors, a regulated platform for capital formation, and a stronger platform from which to engage future research partners and commercial counterparties. The capital raised will be deployed primarily to fund research activities, secure and protect additional valuable intellectual property, and support general working capital.
Outlook
The quantum computing sector remains at an early stage, characterised by high research intensity, significant technical challenges, and substantial capital requirements. The Board is mindful of these realities but equally confident in the asymmetric value potential of breakthroughs that successfully bridge the gap between theoretical physics and commercial application.
Over the coming 12–24 months, our operational priorities are clear:
-- To deliver meaningful progress under the UofT research programme, with
milestones linked to the development of patentable technology;
-- To protect and commercialise intellectual property through provisional
and full patent filings;
-- To seek additional sponsored research agreements with leading academic
and industry partners, diversifying our research pipeline; and
-- To engage with potential licensees and strategic partners who can help
accelerate application and deployment of Delta’s technologies across
global markets.
The Board remains focused on delivering shareholder value through scientific rigour, strategic discipline and transparent engagement with the investing community. I would like to extend my gratitude to our research partners, advisers, and all shareholders for their trust and support. We look forward to updating the market on our continued progress as Delta advances through this exciting stage of development.
Mark Burnett
Non-Executive Chairman
Delta Gold Technologies PLC
Full RNS Link: polaris.brighterir.com/public/delta_gold_technologies_plc/news/rns/story/rd6m1mx